MXPA03001060A - Composiciones para mejorar el trastorno de hiperactividad con deficit de atencion. - Google Patents

Composiciones para mejorar el trastorno de hiperactividad con deficit de atencion.

Info

Publication number
MXPA03001060A
MXPA03001060A MXPA03001060A MXPA03001060A MXPA03001060A MX PA03001060 A MXPA03001060 A MX PA03001060A MX PA03001060 A MXPA03001060 A MX PA03001060A MX PA03001060 A MXPA03001060 A MX PA03001060A MX PA03001060 A MXPA03001060 A MX PA03001060A
Authority
MX
Mexico
Prior art keywords
deficient
hyperactivity disorder
compositions
ameliorating attention
ameliorating
Prior art date
Application number
MXPA03001060A
Other languages
English (en)
Inventor
Makoto Ozeki
Original Assignee
Taiyo Kagaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku Kk filed Critical Taiyo Kagaku Kk
Publication of MXPA03001060A publication Critical patent/MXPA03001060A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion para mejorar el trastorno de hiperactividad con deficit de atencion, caracterizada porque la composicion comprende teanina; y un metodo para mejorar el trastorno de hiperactividad con deficit de atencion, que comprende el paso de administrar teanina a un individuo.
MXPA03001060A 2001-06-06 2001-09-07 Composiciones para mejorar el trastorno de hiperactividad con deficit de atencion. MXPA03001060A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001171342A JP4812968B2 (ja) 2001-06-06 2001-06-06 注意欠陥多動性障害改善用組成物
PCT/JP2001/007763 WO2002100393A1 (en) 2001-06-06 2001-09-07 Compositions for ameliorating attention-deficient/hyperactivity disorder

Publications (1)

Publication Number Publication Date
MXPA03001060A true MXPA03001060A (es) 2003-05-27

Family

ID=19013123

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001060A MXPA03001060A (es) 2001-06-06 2001-09-07 Composiciones para mejorar el trastorno de hiperactividad con deficit de atencion.

Country Status (11)

Country Link
US (1) US20060004026A1 (es)
EP (1) EP1393725B1 (es)
JP (1) JP4812968B2 (es)
KR (1) KR100519574B1 (es)
CN (1) CN1212836C (es)
AT (1) ATE464894T1 (es)
AU (1) AU2001284470B2 (es)
CA (1) CA2417837C (es)
DE (1) DE60141918D1 (es)
MX (1) MXPA03001060A (es)
WO (1) WO2002100393A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5005879B2 (ja) * 2004-02-18 2012-08-22 太陽化学株式会社 抗ストレス及びリラックス用組成物
EP1819241B1 (en) * 2004-12-08 2014-04-30 Unilever PLC Food or beverage product comprising theanine and caffeine for enhancing mental alertness
US8945655B2 (en) * 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
US20090155420A1 (en) * 2007-12-12 2009-06-18 Conopco, Inc., D/B/A Unilever Food product with stabilized non-protein amino acids
KR100945462B1 (ko) * 2008-03-27 2010-03-05 주식회사 하이리빙 중금속의 체내 흡수 억제 및 체외 배출에 효과가 있는 식물성 식품조성물 및 이를 포함하는 건강식품
PL2343987T3 (pl) * 2008-11-11 2013-05-31 Unilever Nv Herbaciana kompozycja
CN102526347B (zh) * 2012-03-14 2014-12-17 上海善力健保健食品有限公司 一种具有改善记忆及脑功能保健品及制作方法
CN102755490B (zh) * 2012-07-03 2013-10-23 杨振刚 九香散加味治疗帕金森病
JP7037161B2 (ja) * 2016-07-07 2022-03-16 株式会社東洋新薬 経口組成物
CN110237062A (zh) * 2019-07-10 2019-09-17 吉林农业大学 一种以葡萄糖胺为调节剂的能够增强注意力的制剂
CN111034761A (zh) * 2019-12-23 2020-04-21 江西普正制药股份有限公司 一种杜仲饼干及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0873350A (ja) * 1994-09-06 1996-03-19 Itouen:Kk 脳機能改善剤、食品及び飲料
JP4627813B2 (ja) * 1995-06-27 2011-02-09 太陽化学株式会社 テアニン含有組成物
JPH0940568A (ja) * 1995-07-31 1997-02-10 Itouen:Kk カフェイン興奮作用抑制剤
US5869528A (en) * 1997-07-22 1999-02-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of attention-deficit/hyperactive disorders
AU2548899A (en) * 1998-02-23 1999-09-06 Taiyo Kagaku Co. Ltd. Composition comprising theanine
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
JP4669095B2 (ja) * 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
US6520921B1 (en) * 2000-06-20 2003-02-18 Eastman Kodak Company Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication
JP5300167B2 (ja) * 2001-08-24 2013-09-25 太陽化学株式会社 気分障害治療用組成物
US7455002B2 (en) * 2004-12-23 2008-11-25 The Goodyear Tire & Rubber Company Method for cutting elastomeric materials and the article made by the method

Also Published As

Publication number Publication date
ATE464894T1 (de) 2010-05-15
CN1449283A (zh) 2003-10-15
CA2417837C (en) 2009-08-04
EP1393725B1 (en) 2010-04-21
CA2417837A1 (en) 2003-01-29
CN1212836C (zh) 2005-08-03
KR100519574B1 (ko) 2005-10-07
JP2002363074A (ja) 2002-12-18
EP1393725A1 (en) 2004-03-03
AU2001284470B2 (en) 2004-06-03
JP4812968B2 (ja) 2011-11-09
KR20030022366A (ko) 2003-03-15
DE60141918D1 (de) 2010-06-02
EP1393725A4 (en) 2006-03-08
US20060004026A1 (en) 2006-01-05
WO2002100393A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
PL350456A1 (en) N−cyanomethylamides as protease inhibitors
WO2003103603A3 (en) NEW FORMIATE-TYPE SALT OF O-DESMETHYLVENLAFAXINE
MXPA06001494A (es) Compuestos de piramidina condensados como inhibidores de canales ionicos gatillados por tension.
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
TW200510375A (en) New compounds
BRPI0411316A (pt) uso de uma toxina clostrìdica para reduzir o apetite
AU2004263179A8 (en) Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
MY129348A (en) Stable polymorph of n-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4- quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004779A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
HRP20041071A2 (en) Methods of treating hepatitis
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
MXPA03001060A (es) Composiciones para mejorar el trastorno de hiperactividad con deficit de atencion.
MXPA02010149A (es) Composiciones de compuestos bioquimicos comprendidos en el metabolismo de bioenergia de las celulas y metodo de uso..
PL362290A1 (en) Tramadol-based medicament
DE60215139D1 (en) Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
PL372457A1 (en) New pharmaceutical compositions containing flibanserin polymorph a
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2003271811A8 (en) Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same
AU2001284470A1 (en) Compositions for ameliorating attention-deficient/hyperactivity disorder
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
UA81664C2 (ru) Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов
UA84302C2 (ru) Изопентилкарбоксанилиды и способ борьбы с нежелательными микроорганизмами
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal